{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05682144",
            "orgStudyIdInfo": {
                "id": "MT2021-24"
            },
            "organization": {
                "fullName": "Immusoft of CA, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I",
            "officialTitle": "A Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Adult Patients With Mucopolysaccharidosis Type I Hurler-Scheie and Scheie",
            "therapeuticArea": [
                "Other"
            ],
            "study": "isp-sleeping-beauty-transposon-engineered-b-cells-for-mps-i"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2023-04-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-06-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2039-06-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-12-12",
            "studyFirstSubmitQcDate": "2023-01-03",
            "studyFirstPostDateStruct": {
                "date": "2023-01-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-13",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Immusoft of CA, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A first-in-human study using ISP-001 in adult patients with Mucopolysaccharidosis Type I Hurler-Scheie and Scheie.",
            "detailedDescription": "This is a Phase 1, first-in-human, open-label, single-arm study in which adult patients with Mucopolysaccharidosis Type I Hurler-Scheie and Scheie are treated with autologous plasmablasts engineered to express \u03b1-L-iduronidase (IDUA) using the Sleeping Beauty transposon system (ISP-001). This study will evaluate the safety and tolerability of ISP-001."
        },
        "conditionsModule": {
            "conditions": [
                "Mucopolysaccharidosis IH/S",
                "Mucopolysaccharidosis IS"
            ],
            "keywords": [
                "MPS IH/S",
                "MPS IS"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 2,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Autologous Plasmablasts (B cells)",
                    "type": "EXPERIMENTAL",
                    "description": "Dose Level: 5 x 10e7 cells/kg on Day 0",
                    "interventionNames": [
                        "Biological: Autologous Plasmablasts (B cells)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "Autologous Plasmablasts (B cells)",
                    "description": "Autologous plasmablasts (B cells) engineered to express \u03b1-L-iduronidase (IDUA) using the Sleeping Beauty (SB) transposon system.",
                    "armGroupLabels": [
                        "Autologous Plasmablasts (B cells)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of participants with treatment-related adverse events and serious adverse events",
                    "description": "Incidence of Adverse Events as assessed by CTCAE (v 5.0)",
                    "timeFrame": "24 Weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of participants with treatment-related adverse events and serious adverse events",
                    "description": "Incidence of Adverse Events as assessed by CTCAE (v 5.0)",
                    "timeFrame": "48 Weeks"
                },
                {
                    "measure": "Determination of Absolute Numbers of B and T cell populations",
                    "description": "Determination of Absolute Numbers of B and T cell populations in peripheral blood at baseline and at scheduled time points post infusion.",
                    "timeFrame": "1Year"
                },
                {
                    "measure": "Concentration of IDUA",
                    "description": "Determine IDUA concentration in plasma at baseline and at scheduled time points post infusion.",
                    "timeFrame": "1 Year"
                },
                {
                    "measure": "Assessment of Storage Material (glycosaminoglycan, or GAG)",
                    "description": "Assessment of Storage Material (glycosaminoglycan, or GAG) in urine at baseline and at scheduled time points post infusion.",
                    "timeFrame": "1 Year"
                },
                {
                    "measure": "Levels of Circulating Antibodies (IgG, IgM, IgA, and IgE)",
                    "description": "Determine levels of circulating antibodies (IgG, IgM, IgA, and IgE) at baseline and at scheduled time points post infusion.",
                    "timeFrame": "1 Year"
                },
                {
                    "measure": "Analysis of PBMCs",
                    "description": "PBMCs will be analyzed at baseline and at scheduled time points post infusion.",
                    "timeFrame": "1 Year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of Mucopolysaccharidosis type I Hurler-Scheie or Scheie syndrome.\n* Age \u2265 18 years at time of study registration.\n* Creatinine clearance, calculated or measured directly, that is \\>60ml/min/1.73m2.\n* Ejection fraction \u2265 40% by echocardiogram.\n* Must commit to traveling to the study site for the necessary follow-up evaluations.\n* Must agree to stay \\<45-minute drive from the study site for a minimum of 5 days after cell infusion.\n\nExclusion Criteria:\n\n* Known familial inherited cancer syndrome. Suspected cases will be investigated, per the physicians discretion, using relevant genetic tests to determine presence of germline mutations.\n* History of B cell related cancer, EBV lymphoproliferative disease or autoimmune disorders.\n* Evidence of active graft-vs-host disease.\n* Underwent a previous hematopoietic stem cell transplant (HSCT).\n* Requirement for systemic immune suppression.\n* Requirement for continuous supplemental oxygen.\n* Any medical condition likely to interfere with assessment of safety or efficacy of the study treatment.\n* In the investigator's judgement, the subject is unlikely to complete all protocol-required study visits or procedures, including follow up visits, or comply with the study requirements for participation.\n\nOther protocol defined inclusion/exclusion criteria may apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jake Wesley, PharmD, MS",
                    "role": "CONTACT",
                    "email": "jake.wesley@immusoft.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Immusoft Clinical Development",
                    "affiliation": "Immusoft of CA, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Minnesota",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55455",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Paul Orchard, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009083",
                    "term": "Mucopolysaccharidoses"
                },
                {
                    "id": "D000008059",
                    "term": "Mucopolysaccharidosis I"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002239",
                    "term": "Carbohydrate Metabolism, Inborn Errors"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000016464",
                    "term": "Lysosomal Storage Diseases"
                },
                {
                    "id": "D000017520",
                    "term": "Mucinoses"
                },
                {
                    "id": "D000003240",
                    "term": "Connective Tissue Diseases"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12041",
                    "name": "Mucopolysaccharidoses",
                    "asFound": "Mucopolysaccharidosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11059",
                    "name": "Mucopolysaccharidosis I",
                    "asFound": "Mucopolysaccharidosis IS",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M5498",
                    "name": "Carbohydrate Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M18871",
                    "name": "Lysosomal Storage Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M19781",
                    "name": "Mucinoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M6464",
                    "name": "Connective Tissue Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3901",
                    "name": "Mucopolysaccharidosis",
                    "asFound": "Mucopolysaccharidosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3902",
                    "name": "Mucopolysaccharidosis Type I",
                    "asFound": "Mucopolysaccharidosis IS",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2853",
                    "name": "Hurler Syndrome",
                    "asFound": "Mucopolysaccharidosis IH",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5124",
                    "name": "Scheie Syndrome",
                    "asFound": "Mucopolysaccharidosis IS",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2854",
                    "name": "Hurler\u00e2\u20ac\u201cScheie Syndrome",
                    "asFound": "Mucopolysaccharidosis IH/S",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}